Skip to main content

Table 1 Descriptive statistics including diagnoses and group differences

From: Anorexia nervosa during COVID-19: loss of personal control and alexithymia as important contributors to symptomatology in adolescent girls

Variables

AN Group

Control Group

Group comparisons

Sample size

29

23

 

Age

  

Z =  − 0.39, p = 0.694

 M

14.90

15.13

 

 SD

1.61

1.55

 

 Range

12–18

12–18

 

BMI in kg/m2

  

Z =  − 5.18, p < 0.001

 M

15.68

20.25

 

 SD

0.98

2.90

 

BAI

  

Z =  − 3.65, p < 0.001

 M

20.90

7.43

 

 SD

13.54

5.65

 

BDI-II

  

Z =  − 5.31, p < 0.001

 M

26.93

5.43

 

 SD

14.70

4.97

 

EDI-II

  

Z =  − 4.50, p < 0.001

 M

302.76

200.35

 

 SD

82.21

36.66

 

PAQ

  

Z =  − 2.01, p = 0.045

 PAQ Total Score

   

  M

80.34

60.17

 

  SD

34.71

25.06

 

Diagnoses (ICD-10)

N

N

 

 F50.00 Anorexia nervosa, restrictive type

23

 

 F50.01 Anorexia nervosa, active type

5

 

 F50.1 Atypical anorexia nervosa

1

 

 F32.1 Moderate depressive episode

10

 

 F33.1 Recurrent depressive disorder, moderate episode

1

 

 F40.1 Social phobia

2

  

 F42.2 Mixed obsessional thoughts and acts

2

 

 F66.0 Sexual maturation disorder

1

 

 F81.0 Specific reading disorder

1

 
  1. AN anorexia nervosa, BAI Beck’s Anxiety Inventory, BDI-II Beck’s Depression Inventory-2, EDI-II Eating Disorder Inventory-2, PAQ Perth Alexithymia Questionnaire, DAF Difficulties Appraising Feelings, ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th Revision. For the EDI-II a total score summed over all scales is reported. Several diagnoses were possible per person